SILVERBACK THERAPEUTICS INC's ticker is SBTX and the CUSIP is 82835W108. A total of 74 filers reported holding SILVERBACK THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $905,113 | +9.7% | 239,448 | +94.4% | 0.00% | – |
| Q2 2023 | $825,125 | -35.5% | 123,153 | -37.3% | 0.00% | – |
| Q1 2023 | $1,279,241 | +32.8% | 196,504 | +74.1% | 0.00% | – |
| Q4 2022 | $962,994 | +83.1% | 112,895 | +13.3% | 0.00% | – |
| Q3 2022 | $526,000 | +0.6% | 99,652 | -19.2% | 0.00% | – |
| Q2 2022 | $523,000 | +46.5% | 123,286 | +21.2% | 0.00% | – |
| Q1 2022 | $357,000 | -31.5% | 101,691 | +30.0% | 0.00% | – |
| Q4 2021 | $521,000 | -4.1% | 78,233 | +43.9% | 0.00% | – |
| Q3 2021 | $543,000 | -86.7% | 54,349 | -38.1% | 0.00% | -100.0% |
| Q4 2020 | $4,069,000 | – | 87,813 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Nextech Invest Ltd. | 1,910,029 | $12,721,000 | 3.35% |
| Orbimed Advisors | 8,740,887 | $58,214,000 | 0.75% |
| Nantahala Capital Management | 1,006,462 | $6,703,000 | 0.24% |
| EcoR1 Capital, LLC | 1,060,010 | $7,060,000 | 0.22% |
| Prosight Management, LP | 53,815 | $358,000 | 0.21% |
| RA Capital Management | 1,742,186 | $11,603,000 | 0.20% |
| Endurant Capital Management LP | 84,295 | $561,000 | 0.14% |
| HighVista Strategies LLC | 22,434 | $149,000 | 0.12% |
| XTX Topco Ltd | 18,816 | $125,000 | 0.07% |
| WASATCH ADVISORS LP | 1,773,690 | $11,813,000 | 0.05% |